Skip to main content

cystic fibrosis Archives

EHRs, biobanks and Mendelian diseases

Apr. 30, 2020—Electronic health records and biobanks can be effectively combined to detect and study Mendelian diseases such as cystic fibrosis.

Read more


Clarksville boy bounces back after COVID-19 infection

Apr. 29, 2020—After a month of cough, off-and-on fever, not feeling well and isolation, Joseph “Jo Jo” Bostain is back to bouncing on his trampoline, reading Harry Potter books and planting flowers outside his Clarksville home.

Read more


Adults with cystic fibrosis face diabetes risk, spur new research

Aug. 16, 2018—Although cystic fibrosis (CF) has long been known as a pediatric disease, physicians and scientists at Vanderbilt University Medical Center are providing specialized care for an ever-growing population of adults with CF, as well as conducting targeted research expected to improve treatment for these patients.

Read more


VUMC investigators find pathogens work together to infect host

Nov. 3, 2016—Pseudomonas aeruginosa and Staphylococcus aureus — two pathogens that frequently co-infect the lungs of patients with cystic fibrosis — appear to cooperate with each other, Vanderbilt investigators have discovered. When pseudomonas is starved for metal by the host, it shuts down the production of factors that would normally kill staph, promoting a co-infection.

Read more


Study reveals new clues to cystic fibrosis ‘gender gap’

Sep. 15, 2016—A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”

Read more


How ABC transporters move molecules

Jun. 13, 2014—New views of how transporters move molecules across cell membranes are key to understanding how these proteins impact tumor cell drug resistance and inherited diseases such as cystic fibrosis.

Read more


Reversing lipid woes in cystic fibrosis

Mar. 3, 2012—Abnormal levels of fatty acids in the blood and tissues of patients with cystic fibrosis may be reversed by supplementation with the fatty acids DHA and EPA.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more